Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Robinhood (NASDAQ: HOOD) has launched a $1 billion closed-end fund IPO, giving retail investors ...

This tutorial provides a comprehensive guide to setting up and utilizing OpenClaw AI agents for managing autonomous cryptocurrency wallets on both the Base and Solana networks. You will learn how to ...

FDA on Friday said it would restrict GLP-1 ingredients Novo, Lilly shares fell after Hims launched the pill on Thursday Hims said the decision followed discussions with stakeholders "Since launching ...

The National Testing Agency (NTA) has officially released the JEE Main 2026 January session admit card. Candidates who have registered for the exam can now download their hall ticket from the official ...

Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 ...

Jan 13 (Reuters) - U.S. telehealth firm Ro said on Tuesday it has entered a research collaboration with drugmaker Amgen (AMGN.O), opens new tab to examine challenges patients and providers face in ...

Suzuki has opened bookings for its first electric scooter, the Suzuki e-Access, marking the brand’s entry into the Indian electric two-wheeler market. We reviewed the e-Access early last year and the ...

BENGALURU: Space engineering firm Dhruva Space Thursday announced Polar Access-1 (PA-1), its most integrated launch programme so far, under which it will support 10 space missions serving multiple ...

Famous for its white sand and gin-coloured waters, Jamaica is the quintessential Caribbean beach destination. But less than 1% of the island's coastline is accessible to residents. On a road trip ...

The Centers for Medicare & Medicaid Services late last year introduced the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) Model to expand access to select ...

The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for enrollees in Medicare Part D and Medicaid plans, but experts say it's unclear how ...

Both companies are also expanding beyond obesity into adjacent conditions, which could reinforce the long-term investment case. Wegovy remains the only GLP-1 drug proven to reduce heart attacks and ...